221 related articles for article (PubMed ID: 7927137)
1. Mechanism of transfusion-associated graft-versus-host disease.
Yasuda H; Ohto H; Abe R
Fukushima J Med Sci; 1993 Dec; 39(2):69-75. PubMed ID: 7927137
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis of transfusion-associated graft-vs.-host disease: the importance of short tandem repeat analysis.
Sage D; Stanworth S; Turner D; Navarrete C
Transfus Med; 2005 Dec; 15(6):481-5. PubMed ID: 16359419
[TBL] [Abstract][Full Text] [Related]
3. Graft-versus-host disease: introduction and prospect.
Ohto H; Suzuki H; Abe R
Fukushima J Med Sci; 1993 Dec; 39(2):63-7. PubMed ID: 7927136
[TBL] [Abstract][Full Text] [Related]
4. Prevention of transfusion-associated graft-vs-host disease.
Holland PV
Arch Pathol Lab Med; 1989 Mar; 113(3):285-91. PubMed ID: 2645855
[TBL] [Abstract][Full Text] [Related]
5. Transfusion associated graft versus host disease.
Anwar M; Bhatti FA
J Ayub Med Coll Abbottabad; 2003; 15(3):56-8. PubMed ID: 14727344
[TBL] [Abstract][Full Text] [Related]
6. Transfusion-associated graft-versus-host disease.
Rühl H; Bein G; Sachs UJ
Transfus Med Rev; 2009 Jan; 23(1):62-71. PubMed ID: 19056035
[TBL] [Abstract][Full Text] [Related]
7. Transfusion-associated graft-versus-host disease in immunocompetent patients: case series and review of the literature.
Agbaht K; Altintas ND; Topeli A; Gokoz O; Ozcebe O
Transfusion; 2007 Aug; 47(8):1405-11. PubMed ID: 17655584
[TBL] [Abstract][Full Text] [Related]
8. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
9. Transfusion-associated-graft-vs-host disease in a presumed immunocompetent patient.
Arsura EL; Bertelle A; Minkowitz S; Cunningham JN; Grob D
Arch Intern Med; 1988 Sep; 148(9):1941-4. PubMed ID: 3261972
[TBL] [Abstract][Full Text] [Related]
10. Fatal transfusion-associated graft-versus-host disease with concomitant immune hemolysis in a group A combat trauma patient resuscitated with group O fresh whole blood.
Gilstad C; Roschewski M; Wells J; Delmas A; Lackey J; Uribe P; Popa C; Jardeleza T; Roop S
Transfusion; 2012 May; 52(5):930-5. PubMed ID: 21981662
[TBL] [Abstract][Full Text] [Related]
11. Transfusion-associated graft-versus-host disease: an overview and two case reports.
Spector D
Oncol Nurs Forum; 1995; 22(1):97-101. PubMed ID: 7708528
[TBL] [Abstract][Full Text] [Related]
12. Transfusion-associated graft-versus-host disease: a serious residual risk of blood transfusion.
Higgins MJ; Blackall DP
Curr Hematol Rep; 2005 Nov; 4(6):470-6. PubMed ID: 16232385
[TBL] [Abstract][Full Text] [Related]
13. Transfusion-associated graft-versus-host disease.
Dwyre DM; Holland PV
Vox Sang; 2008 Aug; 95(2):85-93. PubMed ID: 18544121
[TBL] [Abstract][Full Text] [Related]
14. Transfusion-associated graft-versus-host disease in a liver transplant recipient: an unusual presentation and review of the literature.
O'Brien KL; Pereira SE; Wagner J; Shadman M; Hendrie P; Nelson K; Gernsheimer TB; Price T; Reyes JD; Nester T
Transfusion; 2013 Jan; 53(1):174-80. PubMed ID: 22563807
[TBL] [Abstract][Full Text] [Related]
15. Transfusion-associated graft-versus-host disease.
Rappeport JM
Yale J Biol Med; 1990; 63(5):445-54. PubMed ID: 2293503
[TBL] [Abstract][Full Text] [Related]
16. The impact of universal leukodepletion of the blood supply on hemovigilance reports of posttransfusion purpura and transfusion-associated graft-versus-host disease.
Williamson LM; Stainsby D; Jones H; Love E; Chapman CE; Navarrete C; Lucas G; Beatty C; Casbard A; Cohen H
Transfusion; 2007 Aug; 47(8):1455-67. PubMed ID: 17655590
[TBL] [Abstract][Full Text] [Related]
17. Fatal graft-versus-host disease after living donor liver transplantation: differential impact of donor-dominant one-way HLA matching.
Kamei H; Oike F; Fujimoto Y; Yamamoto H; Tanaka K; Kiuchi T
Liver Transpl; 2006 Jan; 12(1):140-5. PubMed ID: 16382466
[TBL] [Abstract][Full Text] [Related]
18. [Graft versus host disease with fatal outcome after administration of filtered erythrocyte concentrates].
Heim MU; Munker R; Sauer H; Wolf-Hornung B; Knabe H; Holler E; Böck M; Mempel W
Beitr Infusionsther; 1992; 30():178-81. PubMed ID: 1284701
[TBL] [Abstract][Full Text] [Related]
19. The putative role of HLA-C recognition in graft versus host disease (GVHD) and graft rejection after unrelated bone marrow transplantation (BMT).
Bishara A; Amar A; Brautbar C; Condiotti R; Lazarovitz V; Nagler A
Exp Hematol; 1995 Dec; 23(14):1667-75. PubMed ID: 8542963
[TBL] [Abstract][Full Text] [Related]
20. HLA homozygosity and shared HLA haplotypes in the development of transfusion-associated graft-versus-host disease.
Shivdasani RA; Anderson KC
Leuk Lymphoma; 1994 Oct; 15(3-4):227-34. PubMed ID: 7866271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
